GeneSight
在场
是其中之一......
Myriad Genetics 是一家在股票代码 MYGN (US) 下上市的公司。
Myriad Genetics 在 2 个国家有直接业务。Myriad Genetics 拥有 4家子公司，其中包括 GeneSight、Myriad Genetics Europe 和 Myriad RBM。
他们在：
高管
查看带有其 2 名主要高管的组织结构图
GeneSight 搜索最多的简介
高管在Myriad Genetics变化
- Jennifer Fox已作为Chief Legal Officer加入公司 (新闻发布的2024八月1号).
创建提醒
跟踪 GeneSight 的高管变动
生物技术
Myriad Genetics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
GeneSight 的最新新闻稿
- GeneSight Mental Health Monitor: Special Election Series Phase III Update | GeneSight
- GeneSight Mental Health Monitor: Special Election Series Update | GeneSight
- Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election | GeneSight
- Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor | GeneSight
- Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing | GeneSight
- Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status | GeneSight
- Nearly Half of BIPOC Individuals Say They Are Dissatisfied with Their Mental Health, according to Myriad Genetics Nationwide Survey | GeneSight
- Is “Manning Up” Bringing Men Down? | GeneSight
- 93% of Adults who Identify as LGBTQ+ Have Used Coping Mechanisms or Addictive Behaviors to Manage their Mental Health, according to Myriad Genetics Nationwide Survey | GeneSight
- 77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey | GeneSight
- View more press releases Close
关于 GeneSight 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Mark Verratti 
